3-Methyloxindole

CAS No. 1504-06-9

3-Methyloxindole( —— )

Catalog No. M12096 CAS No. 1504-06-9

Used as organic synthesis and medicine intermediate.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G 27 In Stock

Biological Information

  • Product Name
    3-Methyloxindole
  • Note
    Research use only, not for human use.
  • Brief Description
    Used as organic synthesis and medicine intermediate.
  • Description
    Used as organic synthesis and medicine intermediate.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1504-06-9
  • Formula Weight
    147.18
  • Molecular Formula
    C9H9NO
  • Purity
    >98% (HPLC)
  • Solubility
    Limited solubility
  • SMILES
    CC1C(=O)NC2=CC=CC=C12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Potchoiba MJ, et al. Am J Vet Res. 1982 Aug; 43(8):1418-23.
molnova catalog
related products
  • JNJ-26990990

    JNJ-26990990 is a broad-spectrum anticonvulsant drug as a second-generation followup to the marketed drug topiramate.

  • 4-methylnonanoic aci...

    4-methylnonanoic acid is a RIFM fragrance and one of the sources of mutton odor.

  • Chitinase, Serratia ...

    Chitinase, Serratia marcescens (EC 3.2.1.14) has partial lysozyme activity and is widely found in bacteria, fungi, animals and some plants. Chitinase belongs to the glycosyl hydrolase family. Chitinase catalyzes chito-oligosaccharide hydrolysis. Chitinases also can serve as prognostic biomarkers of disease progression. Chitinase can be used in the research of pathogenesis of various human fibrotic and inflammatory disorders, particularly those of the lung (idiopathic pulmonary fibrosis, chronic obstructive pulmonary disease, sarcoidosis, and asthma) and the gastrointestinal tract (inflammatory bowel diseases (IBDs) and colon cancer).